Alimera Sciences ROCE
Quel est le ROCE de Alimera Sciences?
Le ROCE de Alimera Sciences Inc. est -0.76%
Quelle est la définition de ROCE?
Le retour sur capital utilisé (ROCE) est un ratio financier qui mesure la rentabilité d'une entreprise et l'efficacité avec laquelle son capital est utilisé.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE des entreprises dans Health Care secteur sur NASDAQ par rapport à Alimera Sciences
Que fait Alimera Sciences?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Entreprises avec roce similaire à Alimera Sciences
- Mercell AS a ROCE de -0.78%
- Orchid Island Capital Inc a ROCE de -0.78%
- Ravi Kumar Distilleries a ROCE de -0.78%
- Stratus Properties a ROCE de -0.77%
- Africa Oil a ROCE de -0.77%
- DLC a ROCE de -0.77%
- Alimera Sciences a ROCE de -0.76%
- ExGen Resources a ROCE de -0.75%
- Heartland Express a ROCE de -0.75%
- FG New America Acquisition a ROCE de -0.75%
- abrdn Life Sciences Investors a ROCE de -0.75%
- Clough Global Opportunities Fund a ROCE de -0.74%
- Tearlach Resources a ROCE de -0.74%